Takeda, a Japanese pharma giant, is back on the acquisition warpath, paying $4 billion for a psoriasis treatment still in trial. There’s a risk the drug fails, but Takeda has cash and needs new money spinners, writes petesweeneypro
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Japan's Takeda to buy Nimbus' psoriasis drug for as much as $6 blnTakeda Pharmaceutical will buy U.S.-based Nimbus Therapeutics' experimental psoriasis drug for up to $6 billion, the Japanese drugmaker said on Tuesday, as it looks to cut reliance on treatments facing loss of patents.
Leer más »
Japan's Takeda to buy psoriasis drug in up to $6 bln deal with NimbusJapan's Takeda Pharmaceutical said on Tuesday it would acquire Nimbus Therapeutics' drug being developed to treat autoimmune conditions such as psoriasis in up to $6 billion deal.
Leer más »
Japanese company's lander rockets toward moon with UAE roverA Tokyo company is aiming for the moon with its own private lander. The lander blasted off from Cape Canaveral on Sunday atop a SpaceX rocket. On board is the United Arab Emirates' first lunar rover and a toylike robot from Japan that's designed to roll around in the gray lunar dust.
Leer más »
Hayao Miyazaki’s next film hits Japanese theaters in 2023The long-in-the-works feature How Do You Live is slated to premiere on July 14th, 2023.
Leer más »
Private Japanese moon lander snaps 1st photos in deep spaceThe Hakuto-R lander is coming online after its Dec. 11 launch.
Leer más »
The Macallan Is Opening a Japanese-Inspired Tasting Menu Restaurant in ChicagoThe M Room will serve both food and drinks featuring the distillery's famed single malts.
Leer más »